Skip to main content

Table 1 The proportion of samples with an rSBA titer >=128 for meningococcal serogroup A (MenA), C (MenC), W (MenW) and Y (MenY) measured before (T0), one month (T1) and one year (T2) after the vaccination

From: Use of saliva to monitor meningococcal vaccine responses: proposing a threshold in saliva as surrogate of protection

Serogroup

T0 N (%)

T1 N (%)

T2 N (%)

All N (%)

MenA

32/197 (16)

195/197 (99)

194/197 (98)

421/597 (71)

MenC

34/416 (8)

415/416 (99)

414/416 (99)

414/416 (99)

MenW

22/200 (11)

198/200 (99)

199/200 (99)

419/600 (70)

MenY

60/199 (30)

199/199 (100)

199/199 (100)

458/597 (77)